Diffusion Pharmaceuticals LLC (Diffusion)

Oncology Corporate Profile

HQ Location

2020 Avon Court, #4
Charlottesville, VA 22902

Company Description

Diffusion Pharmaceuticals is a clinical-stage biotech company developing new, small-molecule drugs that help regulate the movement of oxygen into tissue by a novel mechanism of action. The Company's lead drug, trans sodium crocetinate (TSC), uses this novel mechanism to re-oxygenate the microenvironment of solid cancerous tumors, thereby significantly enhancing tumor cells' response to conventional treatment without additional side effects.

Website: http://diffusionpharma.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
TSC (+ temozolomide)trans sodium crocetinateGlioblastoma Multiforme (GBM)I

View additional information on product candidates here »

Source: http://diffusionpharma.com

Recent News Headlines

There are no news items to display